So we're really excited about the paper that just came out in GEN Biotechnology. The paper is focused on exozymes and really defining or redefining what is meant by cell-free generally and how we use enzymes to enable industrial biomanufacturing to occur. We use the term exozymes broadly to describe that process of engineering an enzyme to function cell-free to be used in a setting where you're actually trying to make something. And so as we try and redefine this language, it allows us to all coalesce around a common terminology so that investors, the scientific community, the laymen, can understand that when we speak about an exozyme, we use this term, we're talking about industrial biomanufacturing and the use of engineered enzymes to actually make things. We thank GEN Biotechnology for the help in doing this and we hope that this is really a new terminology that we can all coalesce around to push the field forward in the future.